title: Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C.
authors.forename: Adrian P
authors.initials: AP
authors.lastname: Mundt
authors.forename: Rahul
authors.initials: R
authors.lastname: Sarkar
authors.forename: Christine
authors.initials: C
authors.lastname: Winter
authors.forename: Martin
authors.initials: M
authors.lastname: Schaefer
authors.forename: Andreas
authors.initials: A
authors.lastname: Ströhle
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015283:Citalopram / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D018450:Disease Progression; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy; D011602:Psychophysiologic Disorders / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy; D011613:Psychotherapy
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D015283:Citalopram